EZH2 and small cell lung carcinoma: In SCLC, it was discovered that the transcriptional repressor chromodomain Y-like (CDYL) recruits EZH2 to the cyclin-dependent kinase inhibitor 1 C (CDKN1C) promoter, leading to its silencing and further contributing to chemoresistance99.